Poster and Platform Presentations — Victor M. Rivera, M.D., FAAN

Click on the Expand plus sign sign to list the poster and platform presentations by year. Then click on the link to view that presentation.

2023

Collapse All | Expand All

 

    9th Joint Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) and European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
    Milan, Italy (Oct. 11-13, 2023)
    • Alonso RN, Rivera V, Carnero Contentti EG, Hamuy Diaz de Bedoya VF, Ciampi E, Silva B, et al. Recommendations on NMOSD treatment in Latin America: Consensus-based RAND/UCLA methodology. Mult Scler. 2023;29(3S):948-9. 
    • Patricio Correa E, Piedra Andrade JS, Carnero Contentti EG, Torres G, Barrera Madera RA, Ortiz Yepez A, et al. Development of a questionnarie to measure quality of life in neuromyelitis optica spectrum disorder patients. A validation study from Latin America. Mult Scler. 2023;29(3S):666-7. 

<2021

Collapse All | Expand All

 

    American Academy of Neurology (AAN)
    Virtual 2021 Annual Meeting (April 17-22, 2021)
    • Rivera V, Repovic P, Adeyemi A, Altincatal A, Perez-Bajandas C, Saldana-King T, et al. Sociodemographic and clinical characteristics of patients with multiple sclerosis by race and ethnicity (NARCRMS Registry). Neurology. 2021;96(15 Suppl):1703. 
    Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)
    Virtual 2021 Annual Meeting (Feb. 25-27, 2021)
    • Rivera V. The reality of MS epidemiology in LATAM. Mult Scler J. 2021;27(1 suppl):6-7. [Oral Presentation] 
    8th Joint Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) and European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
    MS Virtual 2020 (Sept. 11-13, 2020)
    • Rivera V, Repovic P, Adeyemi A, Altincatal A, Perez-Bajandas C, Saldana-King T, et al. Socio-demographic and clinical characteristics of patients with multiple sclerosis by race and ethnicity (NARCRMS registry). Mult Scler. 2020; 26(S3):354. 
    Baylor College of Medicine (BCM)
    Current Neurology 2012 in Houston, Texas (Nov. 3-4, 2012)
    • Stosic M, De Jesus P, McCarthy J, Hutton GJ, Rivera VM. Multiple sclerosis patient treated with natalizumab develops immune thrombocytopenic purpura. Presented at the Baylor College of Medicine (BCM), Current Neurology 2012 in Houston, Texas (Nov. 3-4, 2012).   [View poster]
    American Academy of Neurology (AAN)
    63rd Annual Meeting in Honolulu, Hawaii (April 9-16, 2011)
    • Avila M, Prieto P, Avila-Ornelas J, Stosic M, Amin A, Hutton GJ, et al. Distal limb discoloration in patients with multiple sclerosis - Case series of 41 patients. Neurology. 2011;76(Suppl 4):A290.  [View poster]
    European Neurological Society (ENS)
    20th Annual Meeting in Berlin, Germany (June 19-23, 2010)
    • Uitdehaag B, Constantinescu C, Cornelisse P, Jeffery D, Kappos L, Li D, et al. Associations between annualized relapse rate and long-term exposure to subcutaneous interferon beta-1a in the Prevention of Relapses and disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis (PRISMS) long-term follow-up study. Presented at the European Neurological Society (ENS), 20th Annual Meeting in Berlin, Germany (June 19-23, 2010).   [View poster]
    Consortium of Multiple Sclerosis Centers (CMSC)
    24th Annual Meeting in San Antonio, Texas (June 2-5, 2010)
    • Avila J, Avila M, Stosic M, Robles L, Prieto PG, Hutton GJ, et al. The role of postpartum intravenous corticosteroids in the prevention of relapses in multiple sclerosis. Int J MS Care. 2010;12 Suppl 1:13.  [View poster]
    • Avila M, Hutton G, Rivera VM. Recurrent and multiphasic disseminated encephalomyelitis, case series. Int J MS Care. 2010;12 Suppl 1:14.  [View poster]
    • Avila M, Prieto P, Robles L, Avila J, Stosic M, Hutton G, et al. Distal lower limb discoloration in patients with multiple sclerosis. Int J MS Care. 2010;12 Suppl 1:13-4.  [View poster]
    • Avila M, Prieto P, Robles L, Stosic M, Avila J, Hutton G, et al. Sleep disorders in multiple sclerosis. Int J MS Care. 2010;12 Suppl 1:13.  [View poster]
    • Robles L, Hutton GJ, Rivera VM. Use of natalizumab in Hispanic patients with relapsing remitting multiple sclerosis. Int J MS Care. 2010;12 Suppl 1:58.  [View poster]
    • Thorne BJ, Perez FI, Rivera VM, Hutton GJ. Computer-assisted cognitive rehabilitation for multiple sclerosis — Updated findings. Int J MS Care. 2010;12 Suppl 1:69.  [View poster]
    American Academy of Neurology (AAN)
    62nd Annual Meeting in Toronto, Canada (April 10-17, 2010)
    • Hutton G, Avila M, Prieto PG, Avila J, Rivera V. Multiple sclerosis and other CNS demyelination after treatment with tumor necrosis factor alpha blockers. Neurology. 2010;74(9 Suppl 2):A371.  [View poster]
    American Neurological Association (ANA)
    134th Annual Meeting in Baltimore, Md. (Oct. 11-14, 2009)
    • Bernitsas E, Hutton GJ, Rivera VM. Deep brain stimulation in multiple sclerosis-related Holmes' tremor. Ann Neurol. 2009;66 Suppl 1:S40.  [View poster]
    European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
    25th Congress in Dusseldorf, Germany (Sept. 9-12, 2009)
    • Herbert J, Rivera V, Ford C, Pace A, Hyde R. Effects of natalizumab on relapses and MRI outcomes in Hispanic patients with relapsing multiple sclerosis. Presented at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), 25th Congress in Dusseldorf, Germany (Sept. 9-12, 2009).   [View poster]
    • Rivera V, Weinstock-Guttman B, Beagan J, Al-Sabbagh A, Bennett R, Dangond F. Final results from the Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis study. Presented at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), 25th Congress in Dusseldorf, Germany (Sept. 9-12, 2009).   [View poster]
    Consortium of Multiple Sclerosis Centers (CMSC)
    23rd Annual Meeting in Atlanta, Ga. (May 27-30, 2009)
    • Avila M, Prieto PG, Robles L, Hutton GJ, Rivera VM. Clinical and radiographic improvement of an acutely aggressive case of multiple sclerosis treated with cyclophosphamide. Int J MS Care. 2009;11 Suppl 2:52-3.  [View poster]
    • Avila M, Robles L, Prieto P, Bernitsas E, Stosic M, Hutton GJ, et al. Prevalence of sleep disorders in multiple sclerosis. Int J MS Care. 2009;11 Suppl 2:83.  [View poster]
    • Bernitsas E, Hutton GJ, Rivera VM. Spasmodic dysphonia in MS: A rare symptom or a possible association? Int J MS Care. 2009;11 Suppl 2:31-2.  [View poster]
    • Bernitsas E, Stosic M, Hutton GH, Rivera VM. Seizures in MS patients: A retrospective study. Int J MS Care. 2009;11 Suppl 2:32.  [View poster]
    • Jeffery D, Rivera VM. Long-term sc IFN beta-1a treatment in RRMS: Cumulative dose effects. Int J MS Care. 2009;11 Suppl 2:29-30.  [View poster]
    • Rivera VM, Jeffery D. Continuous vs non-continuous long-term sc IFN beta-1a treatment in RRMS. Int J MS Care. 2009;11 Suppl 2:67.  [View poster]
    • Robles L, Prieto P, DeAlvare L, Hutton GJ, Rivera VM. Diffuse white matter abnormalities and neurologic manifestations in a patient with anti-ro positive antibodies. Case Report. Int J MS Care. 2009;11 Suppl 2:43.  [View poster]
    • Robles L, Prieto P, Rivera VM, Hutton GJ. Occurrence of herpes zoster in multiple sclerosis patients treated with natalizumab. Int J MS Care. 2009;11 Suppl 2:43.  [View poster]
    American Academy of Neurology (AAN)
    61st Annual Meeting in Seattle, Wash. (April 25 - May 2, 2009)
    • Jeffery D, Rivera V. A post-hoc analysis of cumulative dose effects of subcutaneous interferon beta-1a on clinical and MRI outcomes in relapsing-remitting multiple sclerosis: Results over the long term. Neurology. 2009;72(11 Suppl 3):A237.  [View poster]
    • Jeffery D, Rivera V. Long-term effects of interferon beta-1a dose on relapse rate in relapsing-remitting multiple sclerosis: Results from a post- hoc analysis of PRISMS study data. Neurology. 2009;72(11 Suppl 3):A235-6.  [View poster]
    National Multiple Sclerosis Society (NMSS)
    Tykeson Fellows Conference in Chicago, Ill. (Nov. 4-7, 2008)
    • Bernitsas E, Hutton GJ, Rivera VM. Marburg's disease and neuromyelitis optica in brother/sister. Presented at the National Multiple Sclerosis Society (NMSS), Tykeson Fellows Conference in Chicago, Ill. (Nov. 4-7, 2008).   [View poster]
    World Congress on Treatment and Research in Multiple Sclerosis (ACTRIMS + ECTRIMS + LACTRIMS)
    Montreal, Quebec, Canada (Sept. 17-20, 2008)
    • Avila M, Suarez GA, Brandt D, Ramirez J, Hutton GJ, Rivera VM. Menstrual cycle and menopause in patients with multiple sclerosis. How do these affect the symptoms of disease? Mult Scler. 2008;14 Suppl 1:S155.  [View poster]
    • Chaliman RT, Perez FI, Suarez GA, Rivera VM, Hutton GJ. Longitudinal individualized analysis of computer-based cognitive rehabilitation in multiple sclerosis. Mult Scler. 2008;14 Suppl 1:S152.  [View poster]
    • Rivera V, Al-Sabbagh A, Bennett R, Coyle P, Elias S, Mikol D, et al. RENEW study update XVIII: Ongoing evaluation of the safety and tolerability of mitoxantrone in worsening multiple sclerosis. Mult Scler. 2008;14 Suppl 1:S157.  [View poster]
    • Suarez GA, Avila M, Brandt D, Rivera VM, Hutton GJ. Magnetic resonance imaging findings in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler. 2008;14 Suppl 1:S223.  [View poster]
    Consortium of Multiple Sclerosis Centers (CMSC)
    22nd Annual Meeting in Denver, Colo. (May 28-31, 2008)
    • Suarez-Zambrano GA, Ramirez J, Avila M, Brandt D, Escobar BH, Hutton GJ, et al. Silent MRI white matter lesions in patients with CIS suggestive of multiple sclerosis. Int J MS Care. 2008;10 Suppl 1:52.  [View poster]
    American Academy of Neurology (AAN)
    60th Annual Meeting in Chicago, Ill. (April 12-19, 2008)
    • Suarez-Zambrano GA, Pena JA, Avila M, Hutton GJ, Rivera VM. Frequency and severity of restless legs syndrome in multiple sclerosis: A population study from southeast Texas. Neurology. 2008;70(11 Suppl 1):A334.  [View poster]
    Mexican Academy of Neurology
    31st Annual Meeting in Monterrey, Mexico (Oct. 31 - Nov. 5, 2007)
    • Avila M, Ramirez J, Suarez-Zambrano GA, Hutton GJ, Rivera VM. Multiple sclerosis and antiphospholipid syndrome: Case report. Presented at the Mexican Academy of Neurology, 31st Annual Meeting in Monterrey, Mexico (Oct. 31 - Nov. 5, 2007).   [View poster]
    • Avila M, Suarez-Zambrano GA, Ramirez J, Hutton GJ, Rivera VM. Encefalomielitis diseminada recurrente y multifásica reporte de 2 casos. Presented at the Mexican Academy of Neurology, 31st Annual Meeting in Monterrey, Mexico (Oct. 31 - Nov. 5, 2007). [Recurrent Disseminated Encephalomyelitis: Report of 2 Cases]  [View poster]
    • Suarez-Zambrano GA, Escobar BH, Avila M, Ramirez J, Hutton GJ, Rivera VM. Experience with natalizumab in a group of ms patients from southeast Texas. Presented at the Mexican Academy of Neurology, 31st Annual Meeting in Monterrey, Mexico (Oct. 31 - Nov. 5, 2007).   [View poster]
    European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
    23rd Congress in Prague, Czech Republic (Oct. 11-14, 2007)
    • Hutton GJ, Avila M, Suarez-Zambrano GA, Ramirez J, Rivera VM. Recurrent disseminated encephalomyelitis: Report of 2 cases. Presented at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), 23rd Congress in Prague, Czech Republic (Oct. 11-14, 2007).   [View poster]
    • Hutton GJ, Suarez-Zambrano GA, Jafree I, Landero S, Avila M, Rivera VM. Is restless legs syndrome more frequent and severe in the multiple sclerosis population? Study in multiple sclerosis patients from southeast Texas. Presented at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), 23rd Congress in Prague, Czech Republic (Oct. 11-14, 2007).   [View poster]
    Colombian Academy of Neurology
    VIII Meeting in Cali, Colombia (Aug. 16-19, 2007)
    • Suarez-Zambrano GA, Avila M, Landero S, Jafree I, Escobar BH, Ramirez J, et al. Experiencia con natalizumab en 40 pacientes con esclerosis multiple exacerbacion remision. Presented at the Colombian Academy of Neurology, VIII Meeting in Cali, Colombia (Aug. 16-19, 2007).   [View poster]
    Consortium of Multiple Sclerosis Centers (CMSC)
    21st Annual Meeting in Washington, DC (May 30 - June 2, 2007)
    • Jafree I, Hashmi K, Landero S, Suarez G, Hutton GJ, Rivera VM. Multiple sclerosis and other autoimmune diseases. Int J MS Care. 2007;9(2):65.  [View poster]
    • Landero S, Rivera VM, Hutton GJ, Suarez-Zambrano GA, Ramirez J. Behavior of multiple sclerosis during pregnancy and after delivery. Int J MS Care. 2007;9(2):67.  [View poster]
    • Suarez-Zambrano GA, Landero S, Jafree I, Hutton GJ, Rivera VM. Frequency and severity of restless legs syndrome in ms patients from southeast Texas. Int J MS Care. 2007;9(2):77.  [View poster]
    • Suarez-Zambrano GA, Landero S, Jafree I, Hutton GJ, Rivera VM. Multiple sclerosis in African Americans: A cohort from southeast Texas. Int J MS Care. 2007;9(2):77-8.  [View poster]
    • Suarez-Zambrano GA, Perez F, Avila M, Hutton GJ, Rivera VM. Computer-assisted cognitive rehabilitation in patients with multiple sclerosis. Int J MS Care. 2007;9(2):93.  [View poster]
    American Academy of Neurology (AAN)
    59th Annual Meeting in Boston, Mass. (April 28 - May 5, 2007)
    • Rivera VM, Al-Sabbagh A, Bennett R, Coyle P, Mikol D, Panitch H, et al. Ongoing evaluation of the safety and tolerability of mitoxantrone in worsening multiple sclerosis: The RENEW study. Neurology. 2007;68(12 Suppl 1):A275.  [View poster]
    Mexican Academy of Neurology
    30th Annual Meeting in Merida, Yucatan, Mexico (Oct. 30 - Nov. 4, 2006)
    • Suarez-Zambrano GA, Perez F, Avila M, Hutton GJ, Rivera VM. Rehabilitación cognitiva asistida por computadora en pacientes con esclerosis múltiple. Rev Mex Neuroci. 2006;7(5):504.  [View poster]
    Mexican Academy of Neurology
    29th Annual Meeting in Chihuahua, Mexico (Oct. 29 - Nov. 3, 2005)
    • Ordoñez L, Skromne E, Rivera-Olmos VM. Caracterizacion de sindromes clinicos de comportamiento similar a esclerosis multiple. Rev Mex Neuroci. 2005;6(6):540-1.  [View poster]